Startups channel feed – Endpoints News

Startups channel feed

Daphne Koller’s AI startup gets $143M in new cash from a16z, others

5 years ago

Bezos, Paul Allen funds, a16z put up $100M to build an Illumina of human proteins

5 years ago

BARDA offers a tiny startup up to $812M to create a US-based drug manufacturer — and the CEO comes with a price gouging controversy on his résumé

6 years ago

Martin Mackay’s rare disease startup gets $145 million as it enters the clinic

6 years ago

Precision therapy approach secures small biotech $42M haul to combat disease that inspired the Ice Bucket Challenge

6 years ago

Vivek Ramaswamy’s brother, Shankar, spins out on his own, launching audacious gene therapy play

6 years ago

Spun out of George Church's lab, this biotech upstart is mapping the AAV universe for Novartis, Sarepta to gaze

6 years ago

Blood test for cancer detection company Grail rakes in $390M in latest round

6 years ago

'It's pure art': Versant, GV reveal $60M bet that a clearer look at inflammasomes can lead to better drugs

6 years ago

Praxis Precision Medicines launches with $100M and bold sights on long-evasive neurological disorders

6 years ago

The biopharma funding engine motors on, as Chinese biotech raises nearly $280M in monster round

6 years ago

In the heart of Texas, the AveXis crew gathers for another go at gene therapy with $30M and a powerhouse academic pact to start

6 years ago

Third Rock-backed startup's blood test can sniff out cancer in patients with no history of disease

6 years ago

Boehringer Ingelheim VC backs plan to send GMO bacteria after tumors

6 years ago

An oncology upstart with some deep-pocket VC connections has a unicorn-sized venture round to back the pipeline

6 years ago

Mushroom magic draws $80M injection for London-based mental health startup

6 years ago

Nimbus founder Rosana Kapeller has a new company, with $50M and an eye on the ‘repeatome’

6 years ago

It's not developing drugs that bind to RNA, or morphing RNA into a therapeutic — this Cambridge startup has scored $63M to work on RNA-modifying proteins

6 years ago

Big Pharma VC firms put $11M in seed funds behind cancer startup with bold vision

6 years ago

A longtime Laura Shawver fan calls the serial entrepreneur back to the helm of a biotech upstart

6 years ago

Lantern Pharma charts course for IPO with AI platform that shines light on failed cancer drugs

6 years ago

Abundant funding, sparse data: San Francisco startup backs 'real world' model for rare disease drug development

6 years ago

The newest, $86M Third Rock startup chases the tiny biological machines inside of you

6 years ago

Weathering the storm: Another biotech braves Covid-19 in upsized IPO

6 years ago

First page Previous page 52 53 545556 57 58 Next page Last page